07/21/2025
11:05 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form PRE 14A | |
07/16/2025
7:55 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2025
3:05 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2025
8:15 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2025
3:05 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K/A | |
07/08/2025
8:35 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/07/2025
8:29 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form DEFA14A | |
06/26/2025
3:15 PM | Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Wildcat Capital Management, LLC (Filed by)
| Form SCHEDULE 13D/A | |
06/23/2025
3:48 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form DEFA14A | |
06/16/2025
9:51 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form DEF 14A | |
05/29/2025
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
Get the Latest News and Ratings for SLXN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Silexion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/29/2025
9:14 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2025
3:04 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form POS AM | |
05/23/2025
4:00 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2025
8:20 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
4:01 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
05/13/2025
10:36 AM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SCHEDULE 13G/A | |
05/12/2025
11:12 AM | CVI Investments, Inc. (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SCHEDULE 13G/A | |
05/06/2025
7:35 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
05/01/2025
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
04/29/2025
3:10 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form AW | |
04/29/2025
3:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form POS AM | |
04/29/2025
11:10 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
04/27/2025
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
04/23/2025
3:28 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form POS AM | |
04/23/2025
8:53 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2025
3:06 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form POS AM | |
04/10/2025
3:09 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form POS AM | |
04/01/2025
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
04/01/2025
3:45 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
03/28/2025
7:30 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
3:42 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2025
6:27 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
03/14/2025
5:59 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
7:46 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2025
4:31 PM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SCHEDULE 13G | |
01/30/2025
8:26 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2025
7:56 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2025
11:19 AM | CVI Investments, Inc. (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SCHEDULE 13G | |
01/21/2025
4:49 PM | INTRACOASTAL CAPITAL, LLC (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SCHEDULE 13G | |
01/17/2025
5:56 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
BREAKING: The House just passed 3 pro-crypto bills! (Ad) Experts Believe Altcoin Season is Here!
With this new legislation in effect, crypto experts across the country are buzzing in anticipation Click here to discover my #1 Coin To Own Right Now. |
01/17/2025
5:44 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B4 | |
01/15/2025
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
01/15/2025
5:02 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2025
4:02 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-1/A | |
01/14/2025
5:19 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-1/A | |
01/14/2025
5:01 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
5:00 AM | Peled Amnon (Reporting)
Silexion Therapeutics (Issuer)
Silexion Therapeutics Corp (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/17/2024
6:08 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
5:01 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
8:41 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
12/10/2024
8:42 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
12/10/2024
7:48 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2024
5:00 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2024
5:05 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
11/29/2024
5:06 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
11/27/2024
5:01 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2024
3:30 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2024
3:32 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
11/20/2024
5:15 AM | Guangzhou Sino-Israel Bio-Industry Investment Fund LLP (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SC 13D | |
11/14/2024
8:03 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:30 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2024
3:05 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
4:24 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
10/22/2024
8:02 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form DEF 14A | |
10/16/2024
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
10/16/2024
8:32 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
10/10/2024
4:00 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form PRE 14A | |
10/09/2024
5:04 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
10/01/2024
5:53 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/24/2024
6:10 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:05 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:06 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
09/18/2024
3:32 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
09/17/2024
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
09/09/2024
6:33 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
09/09/2024
7:00 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
3:48 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/22/2024
5:44 PM | Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Wildcat Capital Management, LLC (Filed by)
| Form SC 13D | |
08/22/2024
4:23 PM | Moringa Sponsor, LP (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SC 13D | |
08/21/2024
3:45 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
6:38 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Lushi Avner (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:43 PM | Abramov Dror Yosef (Reporting)
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:47 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Shiloah Ilan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:48 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Hadar Ilan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:48 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Horenshtein Hadar Mirit (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:49 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Shirvan Mitchell (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:49 PM | Alon Ruth (Reporting)
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:50 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Noy Shlomo (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:54 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Levin Ilan (Reporting)
Moringa Sponsor, LP (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
7:12 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Potter Leonard (Reporting)
Wildcat Capital Management, LLC (Reporting)
Wildcat Partner Holdings, LP (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Trump’s #1 America First Stock (Ad) America’s industrial comeback is underway — and it’s bigger than anyone expected.
Over $5 trillion has already been pledged to restore U.S. manufacturing. Trump’s tariffs and trade pressure have set off a massive reshoring push, and the flood of investment is still gaining steam.
But while everyone’s watching the big names, one under-the-radar company holds the key tech that could make it all work — and potentially benefit the most. This could be the #1 America First stock of the decade. |
08/15/2024
2:22 PM | Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
| Form CERT | |
08/15/2024
1:45 PM | Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
| Form 8-A12B | |
